Avastin bevacizumab: Phase III data

Top-line data from the Phase III AVANT trial in 3,451 patients who had undergone surgery for high-risk stage II and III colon cancer showed that Avastin plus FOLFOX or XELOX chemotherapy missed the

Read the full 330 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE